miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer

被引：48

作者：

Wang, Shaocheng ^{[1
]}

Chen, Yanyan ^{[1
]}

Yu, Xiongfei ^{[1
]}

Lu, Yimin ^{[1
]}

Wang, Haoao ^{[1
]}

Wu, Fusheng ^{[1
]}

Teng, Lisong ^{[1
]}

机构：

[1] Zhejiang Univ, Affiliated Hosp 1, Dept Surg Oncol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China

来源：

PATHOLOGY RESEARCH AND PRACTICE | 2019年 / 215卷 / 04期

关键词：

miR-129-5p; Gastric cancer; Epithelial mesenchymal transition; HMGB1; Proliferation; GROUP BOX 1; GROWTH; MICROMETASTASIS; METASTASIS;

D O I：

10.1016/j.prp.2018.12.024

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Background: The miR-129-5p has been reported to be aberrant expression and exert vital roles in tumor progression of various malignancies. However, the effects on EMT in gastric cancer and its precise molecular mechanism in gastric cancer remain unclear. Methods and materials: RT-qPCR was performed to evaluate the expression level of miR-129-5p and HMGB1 in cell lines. Cell proliferation was detected via CCK-8. The epithelial mesenchymal transition (EMT) related proteins and the expression of HMGB1 were detected by western blot analysis. Luciferase assays were used to validate binding seeds between miR-129-5p and HMGB1. Results: miR-129-5p was downregulated in gastric cancer cells compared with GES-1. At the same time EMT was promoted in gastric cancer cells compared to GES-1. Overexpression of miR-129-5p inhibited EMT and proliferation. MiR-129-5p negatively and directly targeted HMGB1. HMGB1 was upregulated in gastric cancer cells and HMGB1 knocked-down inhibited EMT and cell proliferation. Conclusion: Taken together, upregulation of miR-129-5p associated with gastric cancer proliferation and EMT, and serves as a potential diagnostic and therapeutic target via miR-129-5p/HMGB1 pathway in gastric cancer.

引用

页码：676 / 682

页数：7

共 50 条

[1] MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression
Feng, J.
Guo, J.
Wang, J-P
Chai, B-F
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (07) : 3665 - 3673
[2] mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1
Luo, Jing
Chen, Jie
He, Li
MEDICAL SCIENCE MONITOR, 2015, 21 : 4122 - 4129
[3] MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1
Wang, Quan
Yu, Jinhai
BIOCHEMISTRY AND CELL BIOLOGY, 2018, 96 (01) : 19 - 25
[4] MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p
Liu, Ke
Huang, Jun
Ni, Jiangdong
Song, Deye
Ding, Muliang
Wang, Junjie
Huang, Xianzhe
Li, Wenzhao
CELL CYCLE, 2017, 16 (06) : 578 - 587
[5] MiR-129-5p protects against myocardial ischemia-reperfusion injury via targeting HMGB1
Chen, Z. -X.
He, D.
Mo, Q. -W.
Xie, L. -P.
Liang, J. -R.
Liu, L.
Fu, W. -J.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4440 - 4450
[6] LINC00501 Inhibits the Growth and Metastasis of Lung Cancer by Mediating miR-129-5p/HMGB1
Wang, Ruo-Tian
Zhang, Yi
Yao, Shu-Yang
Tan, Xiao-Gang
ONCOTARGETS AND THERAPY, 2020, 13 : 7137 - 7149
[7] miR-129-5p ameliorates ischemia-reperfusion injury by targeting HMGB1 in myocardium
Xing, Jingxian
Liu, Junyan
Liu, Juan
Xu, Zesheng
GENERAL PHYSIOLOGY AND BIOPHYSICS, 2020, 39 (05) : 461 - 470
[8] LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis
Wu, Qiong
Meng, Wen-Ying
Jie, Ying
Zhao, Haijian
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (09) : 6750 - 6757
[9] miR-129-5p inhibits prostate cancer proliferation via targeting ETV1
Gao, Ge
Xiu, Dianhui
Yang, Bin
Sun, Daju
Wei, Xin
Ding, Youpeng
Ma, Yanan
Wang, Zhixin
ONCOTARGETS AND THERAPY, 2019, 12 : 3531 - 3544
[10] MiR-129-5p shuttled by human synovial mesenchymal stem cell-derived exosomes relieves IL-1β induced osteoarthritis via targeting HMGB1
Qiu, Min
Liu, Da
Fu, Qin
LIFE SCIENCES, 2021, 269

← 1 2 3 4 5 →